2115 A VALIDATED QUESTIONNAIRE STUDY COMPARING STENT-RELATED SYMPTOMS BETWEEN CONVENTIONAL JJ STENTS AND A NOVEL THERMO-EXPANDABLE SEGMENTAL URETERIC METAL STENT

Abstract

You have accessJournal of UrologyStone Disease: New Technology1 Apr 20102115 A VALIDATED QUESTIONNAIRE STUDY COMPARING STENT-RELATED SYMPTOMS BETWEEN CONVENTIONAL JJ STENTS AND A NOVEL THERMO-EXPANDABLE SEGMENTAL URETERIC METAL STENT Dharmesh Patel, Tamer El-Husseiny, Konstantinos Moraitis, Zafar Maan, Junaid Masood, and Noor Buchholz Dharmesh PatelDharmesh Patel More articles by this author , Tamer El-HusseinyTamer El-Husseiny More articles by this author , Konstantinos MoraitisKonstantinos Moraitis More articles by this author , Zafar MaanZafar Maan More articles by this author , Junaid MasoodJunaid Masood More articles by this author , and Noor BuchholzNoor Buchholz More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2010.02.2202AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES JJ stents have revolutionized the minimally invasive management of malignant and benign ureteric strictures. However, JJ stents are associated with significant morbidity and reduced quality of life. More recently, a permanent thermo-expandable nickel-titanium alloy, segmental ureteric stent (MemokathTM PNN Medical, Denmark) was introduced. We compare symptoms and quality of life in patients with ureteric strictures treated with either JJ stents or Memokath stents. METHODS Over a one year period, validated ureteral stent symptom questionnaires (USSQ) were sent to 70 consecutive patients 4 weeks after insertion of JJ or Memokath TM stents. During this period, a sub-group of patients underwent insertion of both stents and hence completed two questionnaires. The USSQ is a self-administered multidimensional measure designed to evaluate stent-related morbidity in 6 sections: urinary symptoms, body pain, general health, work performance, sexual matters, and additional problems. RESULTS The patients' response rate was 58.5%. Memokath stents were significantly better for the domains of stent related pain, urinary symptoms index and general health compared with JJ stents and also significantly outperformed the JJ stent group in terms of light and heavy activity. Patients opted clearly in favour of Memokath stents for future stent insertion (Table 1). QOL measure JJ stent MMK stent p-value Prospect of living with urinary symptoms 6.0 3.0 0.02 Urinary symptoms index 32.0 21.5 0.048 Pain 18 7 0.009 Light activities 2.0 1.0 0.02 Heavy activities 3.0 2.0 0.04 CONCLUSIONS Patients with Memokath stents have an improved QOL because stent related morbidity is significantly lower than conventional JJ stents. Also Memokath stents don't require frequent exchanges and are more cost-effective. London, United Kingdom© 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 183Issue 4SApril 2010Page: e822 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.MetricsAuthor Information Dharmesh Patel More articles by this author Tamer El-Husseiny More articles by this author Konstantinos Moraitis More articles by this author Zafar Maan More articles by this author Junaid Masood More articles by this author Noor Buchholz More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...